Sustained responders have lower rates of liver-related events and a better quality of life and productivity compared with non-responders/relapsers after antiviral treatment of chr…
S Mauss, J Petersen, T Witthöft, HW Busch, S Christensen, E Zehnter, C John, J Gölz, D Hartmann, B Stade, M Bilzer, D Hüppe · Zeitschrift für Gastroenterologie · 2013 · Heft 01
Bibliografische Angaben
Zusammenfassung
Background: Limited data exist regarding liver-related morbidity and health-related quality of life after treatment of chronic HCV infection with interferon (IFN)-based therapies in the real-life setting. We therefore conducted a non-interventional follow-up survey in German gastroenterological practices to compare long-term clinical outcome in patients who achieved sustained virologic response (SVR) or non-SVR after IFN-based HCV treatment. Methods: Patients with chronic hepatitis C who achieved SVR/Non-SVR after IFN-based treatment >3 years ago and who are still under routine medical observation were enrolled…
